Cutler Group’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
6CM
Cutler Group's KYNB Position: Q1 2024 in Review
Cutler Group reduced its Kyntra Bio (KYNB) stake by 74% in Q1 2024, selling an estimated $4.31K and leaving 36 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.
Cutler Group first reported a position in KYNB in Q1 2016 and has held it in 28 quarters since. The position peaked at $1.05M in Q3 2017. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.
- Cutler Group held 36 shares of Kyntra Bio worth $2K as of Q1 2024.
- Cutler Group sold 100 Kyntra Bio shares in Q1 2024, an estimated $4.31K.
- Kyntra Bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1834 holding.
- Cutler Group first reported a position in Kyntra Bio in Q1 2016 and has held it in 28 quarters since.
- Cutler Group's Kyntra Bio position peaked at $1.05M in Q3 2017.
- 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.